Agree To Purchase Biogen At $270, Earn 9.1% Annualized Using Options

Investors considering a purchase of Biogen Inc (BIIB) stock, but tentative about paying the going market price of $293.12/share, might benefit from considering selling puts among the alternative strategies at their disposal. One interesting put contract in particular, is the October put at the $270 strike, which has a bid at the time of this writing of $16.20..